These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29159866)

  • 1. Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study.
    Babaei M; Balavarca Y; Jansen L; Lemmens V; van Erning FN; van Eycken L; Vaes E; Sjövall A; Glimelius B; Ulrich CM; Schrotz-King P; Brenner H
    Int J Cancer; 2018 Apr; 142(7):1480-1489. PubMed ID: 29159866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant chemotherapy and relative survival of patients with stage II colon cancer - A EURECCA international comparison between the Netherlands, Denmark, Sweden, England, Ireland, Belgium, and Lithuania.
    Breugom AJ; Bastiaannet E; Boelens PG; Iversen LH; Martling A; Johansson R; Evans T; Lawton S; O'Brien KM; Van Eycken E; Janciauskiene R; Liefers GJ; Cervantes A; Lemmens VE; van de Velde CJ
    Eur J Cancer; 2016 Aug; 63():110-7. PubMed ID: 27299663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort.
    Hines RB; Bimali M; Johnson AM; Bayakly AR; Collins TC
    Cancer Epidemiol; 2016 Oct; 44():77-83. PubMed ID: 27513721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use and Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer: A Population-Based Study.
    Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
    J Natl Compr Canc Netw; 2016 Jan; 14(1):47-56. PubMed ID: 26733554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.
    Yothers G; Sargent DJ; Wolmark N; Goldberg RM; O'Connell MJ; Benedetti JK; Saltz LB; Dignam JJ; Blackstock AW;
    J Natl Cancer Inst; 2011 Oct; 103(20):1498-506. PubMed ID: 21997132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underutilization or appropriate care? Assessing adjuvant chemotherapy use and survival in 3 heterogenous subpopulations with stage II/III colorectal cancer within a large integrated health system.
    Chen Y; Shankaran V; Hahn EE; Haupt EC; Bansal A
    J Manag Care Spec Pharm; 2023 Jun; 29(6):635-646. PubMed ID: 37276035
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of adjuvant chemotherapy on survival benefit in stage III colon cancer patients stratified by age: a Japanese real-world cohort study.
    Kawamura H; Morishima T; Sato A; Honda M; Miyashiro I
    BMC Cancer; 2020 Jan; 20(1):19. PubMed ID: 31906959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased adjuvant treatment and improved survival in elderly stage III colon cancer patients in The Netherlands.
    van Steenbergen LN; Lemmens VEPP; Rutten HJT; Wymenga ANM; Nortier JWR; Janssen-Heijnen MLG
    Ann Oncol; 2012 Nov; 23(11):2805-2811. PubMed ID: 22562836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of adjuvant chemotherapy in older patients with Stage III colon cancer: an observational study.
    van den Broek CBM; Puylaert CCEM; Breugom AJ; Bastiaannet E; de Craen AJM; van de Velde CJH; Liefers GJ; Portielje JEA
    Colorectal Dis; 2017 Oct; 19(10):O358-O364. PubMed ID: 28873267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation.
    Jessup JM; Stewart A; Greene FL; Minsky BD
    JAMA; 2005 Dec; 294(21):2703-11. PubMed ID: 16333005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.
    Keikes L; Koopman M; Lemmens VEPP; VAN Oijen MGH; Punt CJA
    Anticancer Res; 2020 Aug; 40(8):4331-4341. PubMed ID: 32727761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage III colon cancer.
    Sanoff HK; Carpenter WR; Martin CF; Sargent DJ; Meyerhardt JA; Stürmer T; Fine JP; Weeks J; Niland J; Kahn KL; Schymura MJ; Schrag D
    J Natl Cancer Inst; 2012 Feb; 104(3):211-27. PubMed ID: 22266473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of adjuvant chemotherapy for stage II and III colon cancer in France and Italy.
    Bouvier AM; Minicozzi P; Grosclaude P; Bouvier V; Faivre J; Sant M
    Dig Liver Dis; 2013 Aug; 45(8):687-91. PubMed ID: 23428703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant Chemotherapy for Stage II Colon Cancer: Practice Patterns and Effectiveness in the General Population.
    Booth CM; Nanji S; Wei X; Peng Y; Biagi JJ; Hanna TP; Krzyzanowska MK; Mackillop WJ
    Clin Oncol (R Coll Radiol); 2017 Jan; 29(1):e29-e38. PubMed ID: 27663601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study.
    Alwers E; Jansen L; Bläker H; Kloor M; Tagscherer KE; Roth W; Boakye D; Herpel E; Grüllich C; Chang-Claude J; Brenner H; Hoffmeister M
    Mol Oncol; 2020 Feb; 14(2):363-372. PubMed ID: 31816156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months.
    Franken IA; van der Baan FH; Vink GR; May AM; van Grevenstein WMU; Koopman M; Roodhart JML
    Eur J Cancer; 2024 Sep; 208():114207. PubMed ID: 39024724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Benefit of adjuvant 5-fluorouracil based chemotherapy for colon cancer: a retrospective cohort study].
    Mondaca S; Villalón C; Leal JL; Zúñiga Á; Bellolio F; Padilla O; Palma S; Garrido M; Nervi B
    Rev Med Chil; 2016 Feb; 144(2):145-51. PubMed ID: 27092667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused.
    Becerra AZ; Probst CP; Tejani MA; Aquina CT; González MG; Hensley BJ; Noyes K; Monson JR; Fleming FJ
    Surgery; 2015 Sep; 158(3):692-9. PubMed ID: 26032822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.